ABSTRACT
A Have a prevalence of 15-20 per cent in European caucasians B Are more likely to develop thrombocytopenia, nephrotic syndrome
and rash during gold treatment C Are more likely to develop hepatotoxicity following halothane
anaesthesia D Are more likely to develop antinuclear antibodies during
hydralazine therapy E Are more likely to develop agranulocytosis during clozapine therapy
2 Which of the following has the shortest elimination half-life?
